Dynamic Airway CT is Diagnostic for Tracheomalacia in Children
Launched by NYU LANGONE HEALTH · Sep 1, 2023
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new method called Dynamic Airway Computed Tomography (DA-CT) to see if it can effectively diagnose tracheomalacia in children. Tracheomalacia is a condition where the airway is softer than normal, which can cause breathing problems. Currently, the standard way to diagnose this condition is through a procedure called flexible bronchoscopy, which involves inserting a small camera into the airway. The trial aims to determine if DA-CT can provide accurate results without the need for this invasive procedure, while also looking at how good the images are and how much radiation exposure is involved.
Children aged 0 to 18 who have already had a flexible bronchoscopy may be eligible to participate in this study. However, those who are pregnant, breastfeeding, unable to undergo a CT scan without sedation, or have a tracheostomy are not eligible. If your child participates, they will undergo the DA-CT scan, which is a noninvasive procedure that takes detailed pictures of the airway. The results of this pilot study will help researchers plan for a larger study in the future to better understand the potential of DA-CT for diagnosing tracheomalacia.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants 0-18 years old, with
- • Clinically indicated flexible bronchoscopy has been performed
- Exclusion Criteria:
- • Pregnancy or breastfeeding
- • Unable to undergo CT scanning without sedation
- • Patients with tracheostomy
About Nyu Langone Health
NYU Langone Health is a premier academic medical center located in New York City, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a leading sponsor of clinical trials, NYU Langone Health integrates cutting-edge scientific inquiry with patient-centered care, striving to develop new therapies and improve health outcomes across a wide range of medical conditions. The institution is dedicated to fostering collaboration among researchers, clinicians, and patients, ensuring rigorous adherence to ethical standards and regulatory guidelines in all clinical research initiatives. By leveraging its extensive resources and expertise, NYU Langone Health aims to contribute significantly to the advancement of medical knowledge and the enhancement of patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
New York, New York, United States
Patients applied
Trial Officials
Eleanor Muise, MD
Principal Investigator
NYU Langone Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported